I’m so excited to finally share a project @EDWieru and I have been working on! I might be biased but this is my favorite design so far 😉 — check out more of our enamel pins here: https://t.co/PyuNHAwUKb 🤓 #ECMO #FOAMed #MedTwitter #PharmICU #TwitteRx

Congratulations to the Mayo #LVAD program for implanting the first durable BiVentricular Assist Device (#BiVAD) #HeartMate 6 in Minnesota. Thanks to the thoughtful planning and skilled surgical execution of @MVillavicencioT

Wieruszewski et al. 'Dosing Reliability of Direct Thrombin Inhibitors in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis' https://t.co/b4c6MISicK @pwierusz #SystematicReview #ECMO

📢 New in Intensive Care Medicine: Turns out,NE dosing isn’t just science… it’s also a lesson in chemistry + international politics. 🌍💉 🧂 Base vs Salt = confusion everywhere. 👉 Standardization matters-for research, for guidelines, and for patients.🔗 https://t.co/FjEINf29r9

Hot off the Press 👇‼️🚨 A collaborative effort between Mayo, MGH and BMC. https://t.co/XUFRxKxoT4 @pwierusz @CGSNabzdykMD @Elmadhoun @JCVAonline @MayoAnesthesia @MayoClinicCVS @emilynaoum @MayoAnesRes

Hot off the press 🚨

@CritCareReviews A HUGE shout out to my fantastic co-authors for this lovely @yourICM piece! 🙌🏻 @abottussi @pwierusz @md_monaco @KhannaAshishCCM

Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations CCR Journal Watch - tracking the critical care literature daily https://t.co/Sp06oA6IDG

Analysis of 2024 EACTS/EACTAIC/EBCP Guidelines on Cardiopulmonary Bypass in 🔍 How do we balance bleeding vs. thrombosis risk? 💉 When should we reverse DOACs or bridge VKAs? 👥 Why is shared decision-making critical? https://t.co/AiCMH8CWVd #CardiacAnesthesia #CPB

Direct Thrombin Inhibitors in #ECMO 🔎 SR/MA of studies comparing DTIs vs UFH 🔍 28 studies identified, most (25) on bivalirudin 🩸DTIs achieved therapeutic anticoagulation range faster + maintained therapeutic range for > time ⚖️ effects similarly significant in adults (not in

@MayoClinic In his personal time, he enjoys spending time with his wife and two golden retrievers, weightlifting, and traveling. 🐕 #PharmICU

@MayoClinic His research focuses on the understanding of human circulatory physiology, hemodynamic dysregulation, and vascular dysfunction. 📊 #PharmICU

@MayoClinic He has dual academic appointment as Assistant Professor in the fields of Anesthesiology and Pharmacy in the Mayo Clinic College of Medicine. 🎓 #PharmICU

🌟 FCCM Spotlight: Patrick M. Wieruszewski, PharmD, BCCCP, FCCM 🌟​ ​Patrick is a clinical pharmacist and appointed associate in the cardiothoracic surgery ICU and ECMO program at @MayoClinic and serves as Chairman for Clinical Pharmacy Research at Mayo Clinic. #PharmICU

Really enjoyed leading this paper with a great group of Mayo colleagues @pwierusz @JuanGRipoll1

#ECMO in pulmonary embolism: 🩺 rationale & current trends 📄 ECMO in PE treatment guidelines ⏱️ timing of ECMO: reactive vs proactive? 🩸 standalone, bridge to reperfusion, post-treatment support for organ recovery? 💉 concomitant systemic thrombolytics ☢️ concomitant

🚨Hot off the press 👇@MayoAnesthesia @MGHanesthesia @MGBResearchNews @CGSNabzdykMD @pwierusz @JuanGRipoll1

Honored to be inducted as Fellow in the American College of Critical Care Medicine! @SCCM Forever grateful to my caring and loving wife @EDWieru, family, friends, mentors, and colleagues for supporting me to make it possible! @MayoAnesthesia @SCCM_CPP

Another interesting article on @JCVAonline suggesting potential benefit of Ang II in patients requiring RRT Similar findings were reported by #ATHOS investigators on @CritCareMed: https://t.co/QiqMz84VUV @KhannaAshishCCM @giovannilandoni @pwierusz @TomHanffMD @SRAnesthesiaICU

How do you we identify patients more likely to respond to angiotensin II? 🤔 Excited to share our work, signaling ⬇️ ICU and 30-day mortality in patients requiring renal replacement therapy that receive it compared to standard of care! Find it here: https://t.co/YHMcgBoLTi

Great STAR research presentation from @devlinpharmd using big claims data - non-opioid analgesics are underutilized in surgical patients requiring ICU admission, even when full opioid agonists are prescribed. We need to do better! #SCCM2025 #PharmICU